The Association of Serum Irisin with Bone Mineral Density and Turnover Markers in New-Onset Type 2 Diabetic Patients

Table 2

Correlations of serum irisin and BMD with clinical characteristics in the two groups.

		NGT		T2DM
		r		r
Irisin
vs	Age (years)	0.180	0.106	−0.150	0.231
vs	Waist circumference (cm)	0.127	0.255	0.336	0.006
vs	Weight (kg)	0.096	0.391	0.330	0.007
vs	BMI (kg/m^2)	0.072	0.522	0.338	0.006
vs	SBP (mmHg)	0.241	0.029	0.054	0.524
vs	HbA1c (%)	−0.005	0.964	0.167	0.049
vs	TC (mmol/L)	0.125	0.262	0.244	0.004
vs	TG (mmol/L)	0.046	0.683	0.189	0.025
vs	LDL-C (mmol/L)	0.145	0.195	0.388	0.001
vs	P1NP (ng/ml)	−0.006	0.956	−0.201	0.105
vs	OC (ng/ml)	0.123	0.272	−0.143	0.251
vs	β-CTX (ng/L)	0.004	0.968	−0.496	<0.001
vs	25(OH)D (ng/ml)	0.081	0.467	0.044	0.724
vs	Lumbar BMD (g/cm^2)	0.038	0.736	0.189	0.129
Lumbar BMD
vs	Age (years)	−0.248	0.025	−0.209	0.015
vs	Height (cm)	0.223	0.040	0.314	<0.001
vs	BMI (kg/m^2)	0.208	0.060	0.230	0.064
vs	Weight (kg)	0.263	0.017	0.394	0.001
vs	LDL-C (mmol/L)	0.096	0.389	0.279	0.015
vs	P1NP (ng/ml)	−0.247	0.025	−0.160	0.200
vs	OC (ng/ml)	−0.224	0.053	−0.274	0.026
vs	β-CTX (ng/L)	−0.202	0.069	−0.410	0.001
vs	25(OH)D (ng/ml)	−0.019	0.869	0.094	0.454